Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Harvard Business School
Baxter
QuintilesIMS
Teva
US Army
Johnson and Johnson
Covington
Deloitte

Generated: October 22, 2017

DrugPatentWatch Database Preview

VASOTEC Drug Profile

« Back to Dashboard

Which patents cover Vasotec, and what generic Vasotec alternatives are available?

Vasotec is a drug marketed by Biovail Labs Intl and Valeant Pharms North and is included in two NDAs.

The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.

Summary for Tradename: VASOTEC

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list67
Clinical Trials: see list6
Patent Applications: see list5,871
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VASOTEC at DailyMed

Pharmacology for Tradename: VASOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail Labs Intl
VASOTEC
enalaprilat
INJECTABLE;INJECTION019309-001Feb 9, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-002Dec 24, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-005Jul 26, 1988ABRXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-001Dec 24, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-003Dec 24, 1985ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VASOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-003Dec 24, 1985► Subscribe► Subscribe
Biovail Labs Intl
VASOTEC
enalaprilat
INJECTABLE;INJECTION019309-001Feb 9, 1988► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-001Dec 24, 1985► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-002Dec 24, 1985► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-005Jul 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Express Scripts
Fish and Richardson
Novartis
Federal Trade Commission
Teva
QuintilesIMS
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot